Search Results 421-430 of 17980 for Pathogens

1. Olaparib (oral route) - Side effects & dosage - Mayo Clinic

   Olaparib is used as maintenance treatment in patients with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer with a certain type of ...

2. Management of deep bowel endometriosis - Mayo Clinic

   Patients with bowel endometriosis spend on average six years with symptoms before diagnosis. Detection and surgical excision of this disease are challenging ...

3. Mayo Clinic and Whole Biome Announce Collaboration: Joint Development of Microbiome Diagnostic Testing to Focus on Women's Health and Preterm Labor

   Scientific evidence has started mounting that this foodborne pathogen may trigger preterm labor in humans, as well. New tests from the Mayo Clinic-Whole ...

4. Publications - Dana M. Harris, M.D. - Mayo Clinic

   ... pathogen panel testing? Cleve Clin J Med. 2025 Feb 3; 92 (2):83-86 Epub 2025 Feb 03. View PubMed; Al Qady A, Aldhaleei W, Salih M, Ali M, Menakuru S, Nayar KD ...

5. Publications - Kimberly L. Schoonover, M.D. - Mayo Clinic

   SLC29A3 Pathogenic Variants Resulting in Dural Based Fibroinflammatory Mass Lesions and H Syndrome Treated With Cobimetinib: A Case Report. Neurol Genet ...

6. Clonal hematopoiesis clinic stratifies risk for patients with cancer

   Clonal hematopoiesis is the acquisition of somatic pathogenic variants in hematopoietic stem and progenitor cells. These variants can expand over time, and ...

7. Publications - Sindhu R. Nimma, M.D. - Mayo Clinic

   Pantoea agglomerans bacteraemia after uterine artery embolisation: an unusual pathogen. BMJ Case Rep. 2024 Mar 5; 17 (3) Epub 2024 Mar 05. View PubMed; Ardon ...

8. Intrathecally Administered Gene Therapy APB-102 In Rapidly Progressive ALS Patients With SOD1 Mutations - Mayo Clinic

   ... Pathogenic, Pathogenic/Likely Pathogenic, or Likely Pathogenic within the SOD1 gene. Subjects with rapidly progressing disease (“fast” progressors), defined ...

9. Science Saturday: Physicians have new guidelines for managing rare genetic, metabolic disorders - Mayo Clinic News Network

   This disorder is a rare subtype of congenital disorders caused by pathogenic variants in the mannose phosphate isomerase gene. Phosphoglucomutase 1 (GM1-CDG)

10. Meet The Faculty - Pediatric Infectious Diseases Fellowship (Minnesota) - Mayo Clinic College of Medicine & Science

    ... pathogens, all highlight the importance of infectious disease surveillance and management, infection control, appropriate antimicrobial stewardship, and the ...